Enfamil / Reckitt was recently sued relating to a case of NEC (Necrotizing enterocolitis) - a very serious medical condition that is most often associated with premature infants. Breastfeeding has shown to reduce the risk of NEC in infants. & while this lawsuit was far from the first of it’s kind, one first did occur here... the Plaintiff won.
Read on to learn about NEC and what this verdict may mean moving forward!
Necrotizing enterocolitis (NEC) is a serious medical condition that primarily affects premature infants, although it can also occur in full-term infants. It is characterized by inflammation and necrosis (tissue death) of the intestine, particularly the colon and sometimes the small intestine.
Here are some key points about NEC:
Risk Factors: Premature birth is the most significant risk factor for NEC. Infants born prematurely, especially those with very low birth weights, are at the highest risk. Other factors that may contribute to the development of NEC include formula feeding, bacterial colonization of the intestine, and a compromised immune system.
Symptoms: Symptoms of NEC can vary but often include feeding intolerance, abdominal distension, vomiting, diarrhea (which may be bloody), lethargy, temperature instability (hypothermia or fever), and signs of systemic illness such as apnea or bradycardia (slowed heart rate).
Diagnosis: Diagnosis is typically based on clinical symptoms, laboratory tests, and imaging studies such as abdominal X-rays or ultrasounds. In some cases, a diagnosis may be confirmed by examining a sample of intestinal tissue obtained through surgery or a procedure called pneumatosis intestinalis.
Treatment: Treatment for NEC often involves stopping enteral feeding (feeding through the stomach or intestine) and providing intravenous fluids to maintain hydration. Antibiotics are usually administered to treat or prevent bacterial infection. In severe cases, surgery may be necessary to remove necrotic bowel tissue or to repair perforations.
Complications: NEC can lead to serious complications such as intestinal perforation (a hole in the intestine), peritonitis (inflammation of the abdominal lining), sepsis (bloodstream infection), and short bowel syndrome (a condition where insufficient bowel remains for adequate nutrient absorption). These complications can be life-threatening.
Prevention: Strategies to reduce the risk of NEC include promoting breastfeeding, minimizing exposure to unnecessary antibiotics, practicing careful hand hygiene in neonatal units, and avoiding overfeeding or feeding too rapidly.
Necrotizing enterocolitis remains a significant cause of morbidity and mortality in premature infants, despite advances in neonatal care. Early recognition and prompt treatment are crucial for improving outcomes in affected infants.
Breastfeeding can play a major role in reducing the risk of necrotizing enterocolitis (NEC) in premature infants. Here's how breastfeeding can help prevent NEC and why it's beneficial:
Protective Factors in Breast Milk: Breast milk contains numerous components, including antibodies, enzymes, growth factors, and prebiotics, which help protect the infant's immature gastrointestinal tract. These components support the development of a healthy gut microbiome and provide protection against harmful pathogens. Breast milk also contains anti-inflammatory properties that can help reduce intestinal inflammation, a key component in the development of NEC.
Enhanced Gut Maturation: Breastfeeding promotes the maturation of the infant's gastrointestinal tract, which may reduce the susceptibility to NEC. Components found in breast milk, such as human milk oligosaccharides (HMOs), support the growth of beneficial bacteria in the infant's gut, creating a favorable environment that may protect against NEC development.
Reduced Exposure to Potential Pathogens: Breastfeeding can help reduce the risk of infection by providing passive immunity to the infant through the transfer of maternal antibodies. This helps protect against the colonization of the infant's gut by harmful bacteria, viruses, and other pathogens that can contribute to NEC.
Optimal Nutrient Absorption: Breast milk is highly digestible and provides optimal nutrition for the growing premature infant. The components of breast milk are tailored to meet the nutritional needs of preterm infants, supporting growth and development while minimizing the risk of complications such as NEC.
Several studies have demonstrated the protective effects of breastfeeding against NEC. Infants who are exclusively breastfed or receive predominantly breast milk have been shown to have a lower incidence of NEC compared to those who are formula-fed. Additionally, the duration of breastfeeding may also play a role, with longer durations of breastfeeding associated with a decreased risk of NEC. In neonatal intensive care units (NICUs), efforts are often made to support and promote breastfeeding among premature infants as part of NEC prevention strategies.
However, it's essential to acknowledge that breastfeeding may not always be feasible for all infants, particularly those who are critically ill or have specific medical conditions. In such cases, pasteurized donor human milk may be considered as an alternative to formula feeding to provide some of the protective benefits of breast milk.
Legal History and Realities
Lawsuits related to necrotizing enterocolitis (NEC) have been a part of the legal landscape for several decades, often involving allegations of medical malpractice, product liability, or negligence. While specific cases vary in their details and outcomes, here are a few historical examples and trends related to NEC lawsuits:
Early Cases and Awareness: Lawsuits related to NEC began to gain prominence in the latter half of the 20th century as medical understanding of the condition improved, and awareness of its potential causes and risk factors grew. Early cases often involved allegations of negligence against healthcare providers, particularly in cases where timely diagnosis and treatment of NEC were lacking.
Product Liability Claims: In the latter part of the 20th century and into the 21st century, there have been cases where families pursued legal action against manufacturers of infant formula or other medical products, alleging that their products were defective or contributed to the development of NEC. These cases typically involve claims of inadequate quality control, contamination, or improper labeling of products that may have increased the risk of NEC in premature infants.
Litigation Trends: NEC lawsuits have been part of broader trends in medical malpractice litigation, with plaintiffs often seeking compensation for damages such as medical expenses, pain and suffering, loss of income, and long-term care costs associated with NEC-related complications. These lawsuits may involve complex legal and medical issues, requiring expert testimony from healthcare professionals and other specialists to establish liability and quantify damages.
Impact on Healthcare Practices: The threat of litigation has influenced healthcare practices surrounding the prevention, diagnosis, and treatment of NEC. Healthcare providers and institutions may implement protocols and guidelines aimed at reducing the risk of NEC and ensuring timely intervention in suspected cases to mitigate the risk of legal liability.
Legal Precedents and Settlements: Over the years, NEC-related lawsuits have resulted in various legal precedents and settlements, shaping the legal landscape surrounding medical malpractice and product liability claims. Settlements may involve compensation for plaintiffs, as well as agreements to implement changes in healthcare practices or product manufacturing processes to reduce the risk of similar incidents in the future.
Lawsuits related to necrotizing enterocolitis (NEC) can arise in various contexts, often involving allegations of medical malpractice or product liability. Here are a few scenarios where lawsuits related to NEC might occur:
Medical Malpractice: In cases where healthcare providers fail to adhere to the standard of care in the treatment of premature infants, resulting in the development of NEC or exacerbating its severity, families may pursue legal action for medical malpractice. This could include allegations of failure to monitor and detect early signs of NEC, delays in diagnosis or treatment, improper management of feeding protocols, or other forms of negligence in 13
Hospital Negligence: Families may also bring lawsuits against hospitals or healthcare facilities where their infants received care, alleging institutional negligence or systemic failures that contributed to the development of NEC or compromised the quality of care provided. This could involve issues such as understaffing, inadequate training of healthcare personnel, or deficiencies in infection control practices that may have increased the risk of NEC transmission or severity.
Informed Consent: In cases where parents were not adequately informed of the risks associated with certain medical interventions or treatment protocols that may increase the risk of NEC, they may pursue legal action based on lack of informed consent. This could involve allegations that healthcare providers failed to disclose the potential risks and benefits of specific treatments or failed to obtain proper consent before proceeding with procedures that may have contributed to NEC development.
It's important to note that while NEC-related lawsuits can provide recourse for affected families, they also serve as a means to hold healthcare providers and product manufacturers accountable for their actions and decisions. Additionally, these legal proceedings can contribute to ongoing efforts to improve patient safety, advance medical knowledge, and enhance the quality of care provided to premature infants at risk of NEC.
Reckitt / Enfamil current case
"March 14 (Reuters) - An Illinois jury has ordered Reckitt Benckiser unit Mead Johnson to pay $60 million to the mother of a premature baby who died of an intestinal disease after being fed the company's Enfamil baby formula. The jury in an Illinois state court in St. Clair County on Wednesday found that Mead Johnson was negligent and that it failed to warn of the risk of necrotizing enterocolitis (NEC). The disease, which causes the death of bowel tissue, mostly affects premature newborns and has a fatality rate of about 15% to 40%. The $60 million verdict includes compensation for plaintiff's loss and grief, and for the pain and suffering of her baby."
The Plaintiff claims the manufacturer withheld information from families and the medical community about the link between Enfamil and NEC, and the devastating complications that can occur when harmful bacteria breaches the walls of the intestines, causing portions of the tissue to become inflamed or die. The jury said Reckitt, which operates the Mead Johnson Nutrition brand, sold its cow-milk formula knowing it could cause this disease to premature babies. Abbott Nutrition, which is part of Abbott Laboratories faces nearly 1,000 similar lawsuits regarding its Similac formula. This verdict comes in the first trial out of hundreds+ of lawsuits claiming that various Enfamil and Abbott Laboratories' Similac formulas caused NEC.
The NEC lawsuits are separate from ongoing litigation against Abbott over the shutdown of its Sturgis, Michigan, plant and subsequent recall of batches of baby formula for possible contamination, which contributed to a nationwide formula shortage in 2022.
Catch the story from Reuters here:
So what does Reckitt have to say??
Below is the statement released by Reckitt in response to the verdict received in Illinois state court on 13 March in one case concerning Necrotising enterocolotis (NEC):
"Reckitt/Mead Johnson stands by the safety of our products. We strongly reject any assertion that any of our products cause NEC, a serious gastrointestinal problem that mostly affects premature infants.
While we continue to offer our deepest condolences to the mother, we strongly disagree with the jury's decision to fault Mead Johnson and award damages. We continue to believe that the allegations from the plaintiff's lawyers in this case were not supported by the science or experts in the medical community. This was underscored during the trial by a dozen neonatologists.It is important to note that this is a single verdict in a single case and should not be extrapolated.
This case, and others like it, exclusively involve products used under the strict supervision of neonatologists in neonatal intensive care units and provide lifesaving nutrition options for vulnerable premature infants. We are of course, surprised and deeply disappointed with the verdict and will pursue all options to have it overturned"
I think it is safe to say, this will be something to keep an eye on moving forward...
❤❤
Thank you for your support and love in this space! It means more to me than you will ever know.
I truly enjoy sharing this information and I hope you find the information provided valuable. If you do find this information helpful, I kindly ask that you consider sharing - via social media, word of mouth, email, etc. I would love to help support as many out there as I can! <3
Want to make sure you don't miss out on important and valuable information like this?! Hit that link/button below and fill out the quick form! You'll get an email notice when new and important Blog topics are posted + you'll get a copy of my FREE monthly newsletter!!
Fill Out This Quick Form to Get All The Info and Fun!!
Don't Miss Important Info and Updates!
Thank you again for giving Baby Food & Fun, LLC a place to grow and flourish, just like our kids :)
Jessica Enderle, R.D., L.D.
Comments